Alps Dx Launches Xpressor to Improve Oral Fluid Sample Quality
RICHMOND, Va., July 23, 2026 Alps Dx has announced the launch of Xpressorâ„¢ by Alps Dx, an innovative filtration...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
RICHMOND, Va., July 23, 2026 Alps Dx has announced the launch of Xpressorâ„¢ by Alps Dx, an innovative filtration...
WASHINGTON, D.C., July 22, 2026 The U.S. Food and Drug Administration (FDA) has announced two significant regulatory actions aimed...
